Related Experiment Video
Updated: Jun 27, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Hypoglycemia in infants and children.
1The Children's Hospital, 13123 East 16th Avenue, B265, University of Colorado, Denver, USA. hoe.francis@tchden.org
Advances in Pediatrics
|December 4, 2008
Summary
Recent advances explain infant and child hypoglycemia causes, often linked to metabolic or hormonal defects affecting fasting adaptation. Understanding these issues aids in diagnosis and management.
Area of Science:
- Pediatrics
- Endocrinology
- Metabolic Disorders
Background:
- Hypoglycemia in infants and children has diverse causes.
- Defects in metabolic pathways or hormonal regulation are common culprits.
- These defects impair the body's ability to adapt to fasting.
Purpose of the Study:
- To summarize recent advancements in understanding hypoglycemia causes in pediatric populations.
- To highlight the role of fasting adaptation defects.
- To emphasize the importance of the 'critical sample' in diagnosis.
Main Methods:
- Review of current understanding of pediatric hypoglycemia.
- Explanation of metabolic and hormonal control systems during fasting.
- Description of the diagnostic utility of the 'critical sample'.
Main Results:
- Expanded knowledge of diverse hypoglycemia etiologies in children.
- Identification of impaired fasting adaptation as a key factor.
- Validation of the 'critical sample' for assessing fasting system integrity.
Conclusions:
- Understanding the pathophysiology of pediatric hypoglycemia is crucial.
- A rational diagnostic approach is informed by pathophysiology.
- Effective management strategies stem from understanding the underlying causes.
Related Concept Videos
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...